pubmed-article:21126905 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21126905 | lifeskim:mentions | umls-concept:C0010825 | lld:lifeskim |
pubmed-article:21126905 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:21126905 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
pubmed-article:21126905 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:21126905 | lifeskim:mentions | umls-concept:C0599755 | lld:lifeskim |
pubmed-article:21126905 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:21126905 | lifeskim:mentions | umls-concept:C0007328 | lld:lifeskim |
pubmed-article:21126905 | lifeskim:mentions | umls-concept:C0016674 | lld:lifeskim |
pubmed-article:21126905 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:21126905 | pubmed:dateCreated | 2011-1-28 | lld:pubmed |
pubmed-article:21126905 | pubmed:abstractText | CMV reactivation, which enhances immune senescence, could be associated with a higher risk of cancer. | lld:pubmed |
pubmed-article:21126905 | pubmed:language | eng | lld:pubmed |
pubmed-article:21126905 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21126905 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21126905 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21126905 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21126905 | pubmed:month | Feb | lld:pubmed |
pubmed-article:21126905 | pubmed:issn | 1873-5967 | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:DuponMichelM | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:BonnetFabrice... | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:DabisFrançois... | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:FleuryHervéH | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:LafonMarie-Ed... | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:GarrigueIsabe... | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:ThiebautRodol... | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:LazaroEstibal... | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:Faure-Della... | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:BruyandMathia... | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:VandenhendeMa... | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:MarcelGuillau... | lld:pubmed |
pubmed-article:21126905 | pubmed:author | pubmed-author:GeffardStépha... | lld:pubmed |
pubmed-article:21126905 | pubmed:copyrightInfo | Copyright © 2010 Elsevier B.V. All rights reserved. | lld:pubmed |
pubmed-article:21126905 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21126905 | pubmed:volume | 50 | lld:pubmed |
pubmed-article:21126905 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21126905 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21126905 | pubmed:pagination | 177-80 | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:meshHeading | pubmed-meshheading:21126905... | lld:pubmed |
pubmed-article:21126905 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21126905 | pubmed:articleTitle | CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007. | lld:pubmed |
pubmed-article:21126905 | pubmed:affiliation | INSERM U 897 Epidemiology and Biostatistics, Bordeaux, France. | lld:pubmed |
pubmed-article:21126905 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21126905 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |